vTv Therapeutics Inc.
VTVT
$15.35
-$0.65-4.06%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 31.06M | 36.83M | 41.66M | 45.59M | 52.32M |
Total Receivables | -- | 62.00K | 242.00K | 306.00K | 981.00K |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 742.00K | 1.22M | 1.06M | 303.00K | 571.00K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 115.00K | -- | -- | -- | -- |
Total Current Assets | 31.92M | 38.11M | 42.96M | 46.20M | 53.87M |
|
|||||
Total Current Assets | 31.92M | 38.11M | 42.96M | 46.20M | 53.87M |
Net Property, Plant & Equipment | 111.00K | 153.00K | 206.00K | 258.00K | 311.00K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 32.03M | 38.27M | 43.16M | 46.46M | 54.18M |
|
|||||
Total Accounts Payable | 4.19M | 5.97M | 6.23M | 6.79M | 8.73M |
Total Accrued Expenses | -- | 4.09M | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 125.00K | 169.00K | 181.00K | 177.00K | 173.00K |
Total Finance Division Other Current Liabilities | -- | -- | 17.00K | 17.00K | 17.00K |
Total Other Current Liabilities | -- | -- | 17.00K | 17.00K | 17.00K |
Total Current Liabilities | 4.32M | 5.20M | 6.42M | 6.99M | 8.92M |
|
|||||
Total Current Liabilities | 4.32M | 5.20M | 6.42M | 6.99M | 8.92M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | 32.00K | 79.00K | 125.00K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 18.81M | 18.77M | 18.80M | 18.96M | 19.15M |
Total Liabilities | 23.13M | 23.97M | 25.25M | 26.02M | 28.20M |
|
|||||
Common Stock & APIC | 312.73M | 311.92M | 311.09M | 307.78M | 306.92M |
Retained Earnings | -304.81M | -299.72M | -296.08M | -291.30M | -286.12M |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 7.92M | 12.20M | 15.01M | 16.48M | 20.80M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 7.92M | 12.20M | 15.01M | 16.48M | 20.80M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | 977.00K | 2.10M | 2.91M | 3.96M | 5.19M |
Total Equity | 8.90M | 14.30M | 17.91M | 20.44M | 25.99M |
|